Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Health Inks PGx Alliance with OncoMed

NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market Wednesday that it will collaborate with OncoMed Pharmaceuticals in identifying biomarkers that can be applied to clinical development of certain OncoMed antibody cancer drugs.

OncoMed will provide Genomic Health with breast, prostate, colon, and lung tumor samples, and will include a subset of OncoMed's proprietary xenograft models derived from freshly resected human cancers. Genomic Health will use its next-generation sequencing capabilities to discover biomarkers that may help identify patients that are more likely to respond to cancer therapeutics that target the Notch, Wnt and other pathways critical to cancer stem cells.

"This collaboration supports our long-term vision and belief that molecular diagnostics are inherent for bringing quality, personalized care to all cancer patients from diagnosis through survivorship," Genomic Health Chief Medical Officer Steve Shak said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.